KeepItRealistic
1 month ago
$KITT run explained 43,136,957 shares dilution
https://www.otcmarkets.com/filing/html?id=17614814&guid=DeQ-kKaWPL7fJth
We previously entered into an At The Market Offering Agreement (the Sales Agreement), with H.C. Wainwright & Co., LLC, or Wainwright, relating to shares of our common stock, $0.0001 par value per share. In accordance with the terms of the Sales Agreement, we may now offer and sell shares of our common stock having an aggregate offering price of up to $9,858,269 from time to time through or to Wainwright, acting as agent or principal.
From May 20, 2024 through June 11, 2024, the Company issued and sold 43,136,957 shares under this offering for gross proceeds of approximately $8.4 million and net proceeds of approximately $8.0 million, after deducting commissions and offering expenses. As a result, as of June 11, 2024, shares of our common stock with an aggregate offering price of up to approximately $1.5 million remain available for sale in accordance with the terms of the Sales Agreement
INV4
1 month ago
And also this filing:
NAUTICUS ROBOTICS, INC.
FORM 424B3(Prospectus filed pursuant to Rule 424(b)(3))
Filed 06/11/24
This prospectus supplement is being filed to update, amend, and supplement certain information in the prospectus dated May 6, 2024 as supplemented by the prospectus supplement dated May 20, 2024.
We previously entered into an At The Market Offering Agreement (the Sales Agreement), with H.C. Wainwright & Co., LLC, or Wainwright, relating to shares of our common stock, $0.0001 par value per share. In accordance with the terms of the Sales Agreement, we may now offer and sell shares of our common stock having an aggregate offering price of up to $8,355,844 from time to time through or to Wainwright, acting as agent or principal. You should read this prospectus supplement as well as the prospectus supplement dated May 20, 2024 and the accompanying prospectus, as well as the documents incorporated or deemed to be incorporated by reference herein or therein, before you invest.
Our common stock is traded on the Nasdaq Capital Market under the symbol “KITT.” On June 10, 2024, the closing price of our common stock was $0.2309 per share.
Sales of our common stock, if any, under this prospectus supplement may be made in sales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act), including sales made directly on or through the Nasdaq Capital Market, the existing trading market for our common stock, sales made to or through a market maker other than on an exchange or otherwise, directly to Wainwright as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or in any other method permitted by applicable law. Wainwright is not required to sell any specific number or dollar amount of securities but will act as a sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Wainwright and us. There is no arrangement for funds to be received in any escrow, trust, or similar arrangement.
The compensation to Wainwright for sales of common stock sold pursuant to the Sales Agreement will be at a fixed commission rate of 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. In connection with the sale of the common stock on our behalf, Wainwright will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of Wainwright will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Wainwright with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended, or the Exchange Act.
From May 20, 2024 through June 10, 2024, the Company issued and sold 32,406,957 shares under this offering for gross proceeds of approximately $5.4 million and net proceeds of approximately $5.2 million, after deducting commissions and offering expenses. As a result, as of June 10, 2024, shares of our common stock with an aggregate offering price of up to approximately $2,927,753 remain available for the sale in accordance with the terms of the Sales Agreement.
The aggregate market value of the outstanding shares of our common stock held by non-affiliates is approximately $25,067,532, which was calculated in accordance with General Instruction I.B.6 of Form S-3 and is based on 108,564,453 shares outstanding held by non-affiliates, and a price per share of $0.2309, which was the last reported sale price of our common stock on the Nasdaq Capital Market on June 10, 2024. Pursuant to General Instruction I.B.6 of Form S-3, in no event will the aggregate market value of securities sold by us or on our behalf in a primary offering pursuant to the registration statement of which this prospectus forms a part during any 12-calendar-month period exceed one-third of the aggregate market value of our common stock held by non-affiliates, so long as the aggregate market value of our common stock held by non-affiliates is less than $75.0 million. During the 12 calendar months prior to and including the date of this prospectus, we have offered and sold common stock with gross proceeds of $5.4 million pursuant to General Instruction I.B.6 of Form S-3. As a result of these limitations and the current public float of our common stock, and in accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $2,927,753 from time to time through Wainwright. If our public float increases such that we may sell additional amounts under the Sales Agreement and the prospectus, of which the prospectus supplement, as amended by this amendment, is a part, we will file another amendment to the prospectus supplement prior to making additional sales.
We are an emerging growth company and a smaller reporting company as defined under federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. Investing in our securities involves certain risks. See “Risk Factors” on page S-4 of this prospectus supplement and on page 1 of the accompanying prospectus, and in the documents incorporated by reference herein and therein, for a discussion of the factors you should carefully consider before deciding to purchase our common stock.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
H.C. Wainwright & Co.
The date of this prospectus supplement is June 11, 2024.
https://www.otcmarkets.com/filing/conv_pdf?id=17612529&guid=DeQ-kKaWPL7fJth
$KITT
INV4
1 month ago
Hey Jonner, I think it's this filing:
What filing did they submit? I'm not finding I.
NAUTICUS ROBOTICS, INC.
FORM 424B3(Prospectus filed pursuant to Rule 424(b)(3))
Filed 06/12/24
Filed Pursuant to Rule 424(b)(3)
This prospectus supplement is being filed to update, amend, and supplement certain information in the prospectus dated May 6, 2024 as supplemented by the prospectus supplement dated May 20, 2024 and the prospectus supplement dated June 11, 2024.
We previously entered into an At The Market Offering Agreement (the Sales Agreement), with H.C. Wainwright & Co., LLC, or Wainwright, relating to shares of our common stock, $0.0001 par value per share. In accordance with the terms of the Sales Agreement, we may now offer and sell shares of our common stock having an aggregate offering price of up to $9,858,269 from time to time through or to Wainwright, acting as agent or principal. From May 20, 2024 through June 11, 2024, the Company issued and sold 43,136,957 shares under this offering for gross proceeds of approximately $8.4 million and net proceeds of approximately $8.0 million, after deducting commissions and offering expenses. As a result, as of June 11, 2024, shares of our common stock with an aggregate offering price of up to approximately $1.5 million remain available for sale in accordance with the terms of the Sales Agreement. You should read this prospectus supplement as well as the prospectus supplement dated May 20, 2024, the prospectus supplement dated June 11, 2024 and the accompanying prospectus, as well as the documents incorporated or deemed to be incorporated by reference herein or therein, before you invest.
Our common stock is traded on the Nasdaq Capital Market under the symbol “KITT.” On June 11, 2024, the closing price of our common stock was $0.27 per share.
Sales of our common stock, if any, under this prospectus supplement may be made in sales deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act), including sales made directly on or through the Nasdaq Capital Market, the existing trading market for our common stock, sales made to or through a market maker other than on an exchange or otherwise, directly to Wainwright as principal, in negotiated transactions at market prices prevailing at the time of sale or at prices related to such prevailing market prices, and/or in
any other method permitted by applicable law. Wainwright is not required to sell any specific number or dollar amount of securities but will act as a sales agent using commercially reasonable efforts consistent with its normal trading and sales practices, on mutually agreed terms between Wainwright and us. There is no arrangement for funds to be received in any escrow, trust, or similar arrangement.
The compensation to Wainwright for sales of common stock sold pursuant to the Sales Agreement will be at a fixed commission rate of 3.0% of the gross proceeds of any shares of common stock sold under the Sales Agreement. In connection with the sale of the common stock on our behalf, Wainwright will be deemed to be an “underwriter” within the meaning of the Securities Act and the compensation of Wainwright will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to Wainwright with respect to certain liabilities, including liabilities under the Securities Act or the Securities Exchange Act of 1934, as amended, or the Exchange Act.
The aggregate market value of the outstanding shares of our common stock held by non-affiliates is approximately $29,574,807, which was calculated in accordance with General Instruction I.B.6 of Form S-3 and is based on 109,536,324 shares outstanding held by non-affiliates, and a price per share of $0.27, which was the last reported sale price of our common stock on the Nasdaq Capital Market on June 11, 2024. Pursuant to General Instruction I.B.6 of Form S-3, in no event will the aggregate market value of securities sold by us or on our behalf in a primary offering pursuant to the registration statement of which this prospectus forms a part during any 12-calendar-month period exceed one-third of the aggregate market value of our common stock held by non-affiliates, so long as the aggregate market value of our common stock held by non-affiliates is less than $75.0 million. During the 12 calendar months prior to and including the date of this prospectus, we have offered and sold common stock with gross proceeds of $8.4 million pursuant to General Instruction I.B.6 of Form S-3. As a result of these limitations and the current public float of our common stock, and in accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to approximately $1.5 million from time to time through Wainwright. If our public float increases such that we may sell additional amounts under the Sales Agreement and the prospectus, of which the prospectus supplement, as amended by this amendment, is a part, we will file another amendment to the prospectus supplement prior to making additional sales.
We are an emerging growth company and a smaller reporting company as defined under federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for future filings. Investing in our securities involves certain risks. See “Risk Factors” on page S-4 of the prospectus supplement and on page 1 of the accompanying prospectus, and in the documents incorporated by reference herein dated May 20, 2024 and therein, for a discussion of the factors you should carefully consider before deciding to purchase our common stock.
NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
H.C. Wainwright & Co.
The date of this prospectus supplement is June 12, 2024.
https://www.otcmarkets.com/filing/conv_pdf?id=17614814&guid=DeQ-kKaWPL7fJth
$KITT
News
Market Data
Register to chat with like-minded investors on our interactive forums.
Moonboy1
4 hours ago
glenn1919
15 hours ago
Zardiw
16 hours ago
Hole shot King
2 weeks ago
MightyX
1 month ago
1hot toddy
1 month ago
Monksdream
1 month ago
peterus
1 month ago
